Dorian Therapeutics news

To leverage the new wave of enthusiasm, we are thrilled to launch regular Longevity Salons sponsored by 100 Plus Capital to grow a strong community, targeted on onboarding new investors in the space.

100 Plus Capital invests in companies positively impacting human longevity. This can be directly targeted (for example, anti-aging companies) or broader reaching (clean food and water compani

Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system-focused drug discovery, announced today that it had entered into an agreement with Dorian Therapeutics to provide access to one of its novel small molecule libraries specifically designed to target deubiquitylase (DUB) enzymes.

“We hope that this is just the beginning of a fruitful partnership, and that together we will make an impact on the way we treat age-as